Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway

<div>Experimental results of CCK-8 assay. The control group cell viability was set to 100%. This analysis showed that SXSM did not induce cytotoxicity at the 10 mL/L concentration treatment for 48 h and demonstrated the most obvious effect on the NIH-3T3 cell line at the concentration of 1 mL/L.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway 

Figure 3 | Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway 